Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H36O8 |
Molecular Weight | 488.5699 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=FNPXMHRZILFCKX-KAJVQRHHSA-N
InChI=1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1
Molecular Formula | C27H36O8 |
Molecular Weight | 488.5699 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12677094
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12677094
Prednicarbate is a relatively new topical corticosteroid drug. It is similar in potency to hydrocortisone. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy. DERMATOP Ointment (prednicarbate ointment) 0.1% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. Like other topical corticosteroids, prednicarbate has anti-inflammatory, anti-pruritic and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Prednicarbate has a strong correlation between transactivation and glucocorticoid receptor binding.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2034 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12677094 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | DERMATOP Approved UseDERMATOP Ointment 0.1% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. Launch Date1991 |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
43.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8274287/ |
40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered: |
PREDNISOLONE serum | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
158.4 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8274287/ |
40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered: |
PREDNISOLONE 17-ETHYL CARBONATE serum | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
251 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8274287/ |
40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered: |
PREDNISOLONE serum | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
402 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8274287/ |
40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered: |
PREDNISOLONE 17-ETHYL CARBONATE serum | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
0.25 % 1 times / day multiple, topical Recommended Dose: 0.25 %, 1 times / day Route: topical Route: multiple Dose: 0.25 %, 1 times / day Sources: |
unhealthy, 10-90 n = 665 Health Status: unhealthy Condition: dermatitis Age Group: 10-90 Sex: M+F Population Size: 665 Sources: |
Sample Use Guides
Apply a thin film of DERMATOP (prednicarbate) Ointment 0.1% to the affected skin areas twice daily
Route of Administration:
Transdermal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8722602
Prednicarbate (10(-5) M-10(-9) M) caused a comparable dose- and time-dependent inhibition of cytokine release from human leukemic mast (HMC-1) cells stimulated for 24 h with phorbol 12-myristate 13-acetate 25 ng/ml and calcium ionophore 2 x 10(-7) M.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:12 GMT 2023
by
admin
on
Fri Dec 15 14:59:12 GMT 2023
|
Record UNII |
V901LV1K7D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175450
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
||
|
NDF-RT |
N0000175576
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
||
|
WHO-VATC |
QD07AC18
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
||
|
WHO-ATC |
D07AC18
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
PREDNICARBATE
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
6714002
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
V901LV1K7D
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
7605
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
SUB10015MIG
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
2243
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
DB01130
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
277-590-3
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
1554909
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
760042
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
DTXSID9045502
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
m9110
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | Merck Index | ||
|
Prednicarbate
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
4968
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
34369
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | RxNorm | ||
|
73771-04-7
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
V901LV1K7D
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
C035287
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
CHEMBL1200386
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
T-122
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
100000081404
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY | |||
|
C47684
Created by
admin on Fri Dec 15 14:59:12 GMT 2023 , Edited by admin on Fri Dec 15 14:59:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |